Growth Metrics

Teladoc Health (TDOC) Return on Equity (2016 - 2025)

Teladoc Health's Return on Equity history spans 11 years, with the latest figure at 0.14% for Q4 2025.

  • For Q4 2025, Return on Equity rose 52.0% year-over-year to 0.14%; the TTM value through Dec 2025 reached 0.14%, up 52.0%, while the annual FY2025 figure was 0.14%, 39.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.14% at Teladoc Health, up from 0.16% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.03% in Q4 2021 and bottomed at 3.27% in Q4 2022.
  • The 5-year median for Return on Equity is 0.54% (2024), against an average of 0.83%.
  • The largest annual shift saw Return on Equity tumbled -324bps in 2022 before it soared 317bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.03% in 2021, then tumbled by -12108bps to 3.27% in 2022, then surged by 97bps to 0.1% in 2023, then tumbled by -600bps to 0.67% in 2024, then surged by 78bps to 0.14% in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Return on Equity are 0.14% (Q4 2025), 0.16% (Q3 2025), and 0.15% (Q2 2025).